Schapel G J, Hawkins M R, Edwards K D
Aust N Z J Med. 1975 Jun;5(3):202-10. doi: 10.1111/j.1445-5994.1975.tb04569.x.
In 22 digitalized (of a total of 39) patients studied at random by radioimmunoassay during cardiac arrest, the mean serum digoxin concentration was 2.6 (+/- 1.86, range 0.6-8.2) ng/ml, significantly higher (P less than 0.001) than the "eudigitalized" concentration (1.3 +/- 0.52, range 0.5-2.3 ng/ml) determined under carefully standardized conditions in a non-toxic population. Half of the arrest patients had serum digoxin levels in the toxic range (2.4 ng/ml or above), mainly due to significant renal failure (mean serum creatinine concentration 2.9 +/- 2.66 v. 1 +/- 0.26 mg/dl for non-toxic subjects, P less than 0.001), partly due to a higher mean daily digoxin dose (0.40 v 0.31 mg/day, P less than 0.05) and frequently associated with potent diuretic therapy (73 v 54%). A smaller fraction of digitalized patients survived, both short- (27%) and long-term (14%), than did non-digitalized subjects (35% and 26%, respectively). The mean myocardial digoxin concentration was 150 (+/- 63.3, range 52-252) ng/g with an average myocardial/serum ratio of 62.5 (range 38-91). There were significant positive correlations between the serum digoxin and left-ventricular myocardial digoxin concentration (r=0.8107, P less than 0.01) or serum creatinine concentration (r=0.4637, P less than 0.001).
在心脏骤停期间通过放射免疫测定法随机研究的22例(共39例)使用地高辛的患者中,血清地高辛平均浓度为2.6(±1.86,范围0.6 - 8.2)ng/ml,显著高于在无毒人群中在严格标准化条件下测定的“有效使用地高辛”浓度(1.3±0.52,范围0.5 - 2.3 ng/ml)(P<0.001)。一半的心脏骤停患者血清地高辛水平处于中毒范围(2.4 ng/ml或更高),主要是由于严重肾衰竭(中毒患者血清肌酐平均浓度为2.9±2.66,无毒受试者为1±0.26 mg/dl,P<0.001),部分原因是平均每日地高辛剂量较高(0.40对0.31 mg/天,P<0.05),且常与强效利尿治疗相关(73%对54%)。使用地高辛的患者短期(27%)和长期(14%)存活的比例均低于未使用地高辛的受试者(分别为35%和26%)。心肌地高辛平均浓度为150(±63.3,范围52 - 252)ng/g,心肌/血清平均比值为62.5(范围38 - 91)。血清地高辛与左心室心肌地高辛浓度(r = 0.8107,P<0.01)或血清肌酐浓度(r = 0.4637,P<0.001)之间存在显著正相关。